RxDoctor Payments Data

Justin Crane

Physical Medicine & Rehabilitation · Baltimore, MDNPI 1851928089

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Boston Scientific at 32.2% of the total.

$916in general payments, 2019–2025

Across 14 payments — averaging $65.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$295
  • Saluda Medical Americas, Inc.$199
  • Nevro Corp.$147
  • Abbott$145
  • Globus Medical$65
  • AbbVie$25
  • plus $41 from 2 others

What the payments were for

  • Food & beverage$916100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$916 in reported general payments places this provider in the 75th percentile of 202 physical medicine & rehabilitation providers in Maryland.

See all physical medicine & rehabilitation providers in Maryland

Medicare billing

Part B allowed, 2024
$44,136
Medicare patients
276
Services billed
477

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin64$780
Celecoxib19$430
Duloxetine Hcl25$300
Methylprednisolone40$226
Tizanidine Hcl12$214
Oxycodone Hcl24$128
Baclofen14$102
Meloxicam14$34

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →